Complementation Studies in Fanconi Anemia
Fanconi anemia (FA) was originally described as an autosomal recessive disorder characterized by a progressive pancytopenia, diverse congenital abnormalities, and an increased predisposition to the development of malignancy (Fanconi 1967; Schroeder et al. 1976). More recently, it has been recognized that the phenotype is so variable that diagnosis on the basis of clinical manifestations alone is difficult and often unreliable (Glanz and Fraser 1982; Alter and Potter 1983). The enormous clinical variation seen in FA suggests that there is likely to be an underlying genetic heterogeneity.
KeywordsAnemia Fluorescein Guanine Isothiocyanate Mitomycin
Unable to display preview. Download preview PDF.
- Alter BP, Potter NU (1983) Long term outcome in Fanconi’s anemia: description of 26 cases and review of the literature. In: German J (ed) Chromosome mutation and neoplasia. Liss, New York, pp 43–62Google Scholar
- Auerbach AD, Venkatraj VS, Chiorazzi N, Carter DM (1985) Isolation of a human-human hybridoma showing complementation of a gene for hypersensitivity to clastogens. Environ Mutagen 7 (Suppl 3): 47–48Google Scholar
- Thompson LH, Carrano AV (1983) Analysis of mammalian cell mutagenesis and DNA repair using in vitro selected CHO cell mutants. In: Friedberg EC, Bridges BR (eds) Cellular responses to DNA damage, UCLA symposium on molecular and cellular biology, new series, vol 11. Liss, New York, pp 125–143Google Scholar
- Yoshida MC (1982) The absence of genetic heterogeneity in Fanconi’s anemia in five patients demonstrated by somatic cell hybridization. Cytogenet Cell Genet 32: 329–330Google Scholar